FS Development Corp. II (FSII)
| Market Cap | 60.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 6.00M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 53,515 |
| Open | 9.99 |
| Previous Close | 9.99 |
| Day's Range | 9.99 - 10.00 |
| 52-Week Range | 9.85 - 11.17 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About FSII
FS Development Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in San Francisco, California.
News
Pardes Biosciences and FS Development Corp. II Announce Merger Agreement Creating Publicly Listed Biopharmaceutical C...
CARLSBAD, Calif. & LARKSPUR, Calif.--(BUSINESS WIRE)--Pardes Biosciences and FS Development Corp. II announce merger agreement creating publicly listed company advancing oral antiviral drugs.
2 New Healthcare SPACs Worth Adding to Your Watch List
SPAC-mania is in full swing, and the healthcare sector is starting to pop with new offerings.
FS Development Corp. II, Sponsored by Foresite Capital, Announces Pricing of Upsized $175 Million Initial Public Offe...
SAN FRANCISCO--(BUSINESS WIRE)-- #lifesciences--FS Development Corp. II announced today that it priced its initial public offering of 17,500,000 shares of Class A common stock at $10.00 per share.
Foresite Capital's second SPAC FS Development II files for a $100 million IPO
FS Development II, the second blank check company formed by Foresite Capital targeting a healthcare business, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.
FS Development II IPO Registration Document (S-1)
FS Development Corp. II has filed to go public with an IPO on the NASDAQ.